QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 213 filers reported holding QIAGEN NV in Q2 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $415,000 | -75.1% | 8,477 | -71.8% | 0.01% | -52.0% |
| Q4 2021 | $1,668,000 | +99.3% | 30,011 | +85.2% | 0.02% | +25.0% |
| Q3 2021 | $837,000 | +48.1% | 16,208 | +38.6% | 0.02% | +100.0% |
| Q2 2021 | $565,000 | -30.6% | 11,693 | -30.1% | 0.01% | -41.2% |
| Q1 2021 | $814,000 | +27.6% | 16,718 | +38.7% | 0.02% | 0.0% |
| Q4 2020 | $638,000 | -6.3% | 12,054 | -7.4% | 0.02% | 0.0% |
| Q3 2020 | $681,000 | -80.0% | 13,016 | -83.6% | 0.02% | -71.2% |
| Q2 2020 | $3,402,000 | +76.7% | 79,454 | +39.5% | 0.06% | +103.4% |
| Q4 2019 | $1,925,000 | +325.9% | 56,954 | +315.7% | 0.03% | +222.2% |
| Q3 2019 | $452,000 | +39.1% | 13,700 | +60.0% | 0.01% | +50.0% |
| Q3 2018 | $325,000 | +57.0% | 8,565 | +49.6% | 0.01% | +50.0% |
| Q2 2018 | $207,000 | -47.6% | 5,727 | -53.2% | 0.00% | -33.3% |
| Q1 2018 | $395,000 | -70.5% | 12,246 | -69.4% | 0.01% | -62.5% |
| Q2 2017 | $1,340,000 | – | 39,987 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |